Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment

Asunción Fernández-Barral1, Jose Luis Orgaz2, Pablo Baquero3

  • 1Department of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain.

Neoplasia (New York, N.Y.)
|July 18, 2014
PubMed

Insights

Pigment epithelium-derived factor (PEDF) expression is regulated by microphthalmia-associated transcription factor (MITF) in melanoma. This MITF-PEDF axis plays a crucial role in controlling melanoma cell aggressiveness and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pigment epithelium-derived factor (PEDF) exhibits anti-metastatic properties in cutaneous melanoma.
  • The relationship between PEDF and microphthalmia-associated transcription factor (MITF) in melanoma biology is not fully understood.

Purpose of the Study:

  • To investigate the regulatory relationship between MITF and PEDF in melanoma.
  • To elucidate the functional role of the MITF-PEDF axis in melanoma progression and metastasis.

Main Methods:

  • Correlation analysis of PEDF and MITF expression in melanoma cell lines and human samples.
  • MITF gene silencing experiments.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) to identify MITF binding sites.
  • Reporter assays to confirm transcriptional regulation.
  • In vitro and in vivo assays to assess melanoma cell migration, invasion, and dissemination.

Main Results:

  • PEDF expression positively correlates with MITF levels in melanoma.
  • High PEDF and MITF expression are associated with less aggressive melanoma phenotypes.
  • MITF directly binds to the SERPINF1 gene promoter, regulating PEDF transcription.
  • MITF silencing leads to decreased PEDF expression and increased melanoma cell migration, invasion, and dissemination.

Conclusions:

  • PEDF is identified as a novel transcriptional target of MITF in melanoma.
  • The MITF-PEDF axis is a key regulator of melanoma cell aggressiveness and metastatic potential.
  • Targeting the MITF-PEDF pathway may offer therapeutic strategies for melanoma treatment.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K